Stocks_Info_Adda

Sharing valuable stock info regarding swing trading, company concall, IPO trading and VCP trading. Sharing personal views. No buy or sell recommendation.

[Stocks_Info_Adda @prasad0220]

@AndrewBolis Money

[Stocks_Info_Adda @prasad0220]

@WealthEnrich EBGNG

[Stocks_Info_Adda @prasad0220]

@WealthEnrich AI, Pharma , Data centre

[Stocks_Info_Adda @prasad0220]

🚨 Big Win for STL 🚨

Sterlite Technologies subsidiary secures a multi-year Product Award Letter worth ~$1.11B from a hyperscaler for AI-ready optical connectivity solutions in US data centers.
#sterliteTech #stl #stockmarketnews

[Stocks_Info_Adda @prasad0220]

🚨 Upper Circuit Stocks | 10 Mar 2026

• +20% Authum Investment & Infrastructure
• +20% FACT (Fertilisers & Chemicals Travancore)
• +10% Atlanta Electricals
• +5% S&S Power Switchgear
• +5% AAA Technologies
• +5% Aban Offshore
• +5% IZMO
• +5% Akme Fintrade
• +5% McLeod Russel India

#UpperCircuit #StockMarketIndia #Nifty50 #Sensex #SmallCaps #MicroCaps #DalalStreet #IndianStocks #ShareMarket #Investing

[Stocks_Info_Adda @prasad0220]

🚨 Dalal Street Bounce Back!

📈 Nifty50 Recap | 10 Mar 2026

After yesterday’s fear-driven sell-off, bulls roared back today! 🐂🔥

Nifty50 jumps +233 pts to 24,261 (+0.97%)
Sensex rallies +640 pts to 78,206

✨ What changed overnight?
• Crude oil cools after recent spike 🛢️
• Geopolitical tension sentiment eases 🌍
• Strong buying in banking & financial stocks 🏦
• Global markets turn positive

⚡ Market Pulse
• Bank Nifty surges ~900 pts
• India VIX crashes ~19% (fear cooling)
• Broad-based rally across sectors

From panic to relief in just 24 hours — classic market behaviour where sentiment flips faster than fundamentals.

Smart money knows: volatility creates opportunity. 📊

#Nifty50 #Sensex #StockMarketIndia #DalalStreet #MarketRecap #Investing #IndianStocks #StockMarket #Trading

[Stocks_Info_Adda @prasad0220]

Market history repeats the same lesson again and again.
📉 Mar 2020: Nifty crashed to 7,511 — down ~38% in just 40 days.
Panic everywhere. Investors wanted to exit everything.
But those who added fresh capital saw ~140% returns in <18 months.

📉 2022 Correction:
Mid & small caps bled 20–30% in months as sentiment collapsed.
Yet quality companies bounced back with 60–120% gains through 2023–24.

📊 Today:
• Nifty ~8–9% below peak
• FII outflows > ₹1.5 lakh Cr
• Earnings downgrades, AI disruption fears & global war headlines

The irony?
When the future actually becomes clear, prices are already 20–30% higher and everyone suddenly becomes confident again.

Investing was never meant to be easy.
#Nifty50 #StockMarketIndia #Investing #MarketCycles #DalalStreet #LongTermInvesting #FIIs #BearMarket #StockMarket #niftycrash

[Stocks_Info_Adda @prasad0220]

Market bloodbath on Dalal Street.
Rising crude oil prices and escalating Middle East tensions triggered a sharp sell-off, dragging Indian equities lower on Monday. �

📉 Nifty50 Recap | 9 March 2026
• Nifty50: 24,028 ▼422 pts (-1.73%)
• Sensex: 77,566 ▼1,353 pts (-1.71%)

⚠️ Why the Fall?
🌍 Escalating Middle East conflict hurting global sentiment
🛢 Crude oil surge (spiked above $100 during the session)
💸 Continued FII selling pressure
💱 Rupee weakness adding macro concerns �

🧭 Key Levels to Watch
• Support: 24,000
• Resistance: 24,300–24,450

📊 Trend: Nifty has now entered a technical correction zone, falling over 10% from its January record high. �
#Nifty50 #Sensex #StockMarketIndia #DalalStreet #MarketCrash #Investing 📉

[Stocks_Info_Adda @prasad0220]

Raksha Mantri exhorts GRSE to build niche platforms in today’s evolving tech-driven era to realise Govt’s Viksit Bharat goal

#StockMarketIndia #StockMarketNews

[Stocks_Info_Adda @prasad0220]

One of the fastest growing pharma outsourcing companies in India?

Sai Life Sciences ($SAILIFE) is quietly emerging as a major CRDMO player benefiting from the China+1 shift.

Revenue +43%
PAT +199%
But the stock trades at ~60x PE.

1️⃣ What does Sai Life Sciences do?

Sai is a CRDMO (Contract Research, Development & Manufacturing Organization).

In simple terms:
Pharma companies outsource drug development to them.

Sai supports the entire journey:
🔬 Drug discovery
⚗️ Process development
🏭 API manufacturing

It serves 300+ pharma & biotech clients globally.

2️⃣ Strong Financial Growth

📊 9M FY26 numbers
• Revenue: ₹1,590 Cr (+43% YoY)
• EBITDA Margin: 30%
• PAT: ₹245 Cr (+199% YoY)

Margins expanding rapidly as operating leverage kicks in.

3️⃣ The Big Structural Tailwind
Global pharma is reducing dependence on Chinese CRDMOs.
This China+1 shift is driving outsourcing to India.

Sai Life Sciences is emerging as a key beneficiary.

4️⃣ Sticky Pharma Clients
Sai works with:

💊 18 of the top 25 global pharma companies

Once a drug moves into development with a CRDMO partner: Switching becomes extremely difficult.
This creates long-term revenue visibility.

5️⃣ Massive Capacity Expansion

Reactor capacity is increasing:
700 KL → 1,150 KL by FY27
Current utilization: ~60%
Meaning: Future growth can come without proportional capex.

6️⃣ New Growth Engines
Sai is expanding into next-gen drug technologies:
• Peptides
• Oligonucleotides
• ADCs
• AI-driven drug discovery

These areas could significantly expand its TAM.

7️⃣ Management Guidance
Company expects:
📈 15–20% revenue CAGR
📊 28–30% EBITDA margins

If achieved, earnings could scale quickly.

Sai Life Sciences could become a major Indian CRDMO over the next decade driven by:

✔ China+1 outsourcing
✔ Big pharma partnerships
✔ Capacity expansion
✔ High margin business model

But valuation already reflects high expectations.

Tracking stock for long-term pharma outsourcing theme.

📌 Tags

#SaiLife Sciences #SAILIFE #CRDMO #PharmaStocks #IndianPharma #ChinaPlusOne
#HealthcareStocks #MidcapStocks
#StockMarketIndia #FundamentalAnalysis #investing
#IndianPharma #ChinaPlusOne
#HealthcareStocks #MidcapStocks
#StockMarketIndia #FundamentalAnalysis #Investin
#CRDMO #PharmaStocks
#IndianPharma #ChinaPlusOne
#HealthcareStocks #MidcapStocks
#StockMarketIndia #FundamentalAnalysis #Investing

[Stocks_Info_Adda @prasad0220]

Bearish clouds return on Dalal Street.
The relief rally was short-lived as rising Middle East tensions and surging crude oil hit investor sentiment.

📉 Nifty50 Recap | 6 Mar 2026

• Nifty50: 24,450 ▼315 pts (-1.27%)
• Sensex: 78,919 ▼1,097 pts (-1.37%)
⚠️ Why the fall?
🌍 Renewed Middle East tensions
🛢 Brent crude near $85/barrel
🏦 Banking stocks drag (ICICI Bank among laggards)
💰 Persistent FII selling

💰 Institutional Flow
• FIIs: -₹6030 Cr 📉
• DIIs: +₹6971Cr 📈
🧭 Key Levels

Support: 24,300
Resistance: 24,700–24,850
#Nifty50 #Sensex #StockMarketIndia #DalalStreet #CrudeOil #Investing 📊

[Stocks_Info_Adda @prasad0220]

🚨 Big Oil Diplomacy Move
The US has granted India a 30-day waiver to purchase Russian oil amid Iran’s blockade of the Strait of Hormuz.
▪️ Applies only to Russian oil already stuck at sea
▪️ US says the move won’t economically benefit Russia
▪️ Aims to stabilize global oil supply during Middle East tensions
Energy geopolitics just got more complicated. 🛢️
#OilMarket #RussiaOil #IndiaEnergy #StraitOfHormuz #MiddleEast #Geopolitics #CrudeOil #EnergySecurity #GlobalMarkets #BreakingNews

[Stocks_Info_Adda @prasad0220]

🚨 Breaking: SEBI has collected 1.7 TB of email data in the IndusInd Bank insider trading probe.
SAT has rejected the plea of the ex-Deputy CEO seeking access to the emails.
Big development in India's financial regulation space.
#IndusIndBank #SEBI #InsiderTrading #IndianStockMarket #DalalStreet #CorporateGovernance #BusinessNews

[Stocks_Info_Adda @prasad0220]

BIG MOVE: Mazagon Dock $MAZDOCK Clarification
MDL officially breaks silence on the reported ₹99,000 Cr. defence deal! 🚢🇮🇳

The Status:
✅ CNC Negotiations: 100% COMPLETED with the Govt.
✅ Next Step: Proposal submitted for final approval from the competent authority.
✅ Compliance: No undisclosed info or legal hurdles behind the recent price action.

One of India’s biggest naval projects is moving into the home stretch. 🚀

#MazagonDock #DefenseSector #StockMarketIndia #MakeInIndia #Nifty #Investing

[Stocks_Info_Adda @prasad0220]

Bulls strike back! Nifty surges 285 pts as war fears ease — Sensex reclaims 80k!

📈🚀Nifty50 Recap | 5 March 2026Nifty soared ~285 pts ↑ to 24,765 (+1.17%)
Sensex surged 900 pts ↑ to 80,015 (+1.14%)

✨ Why the Rebound?→ De-escalation Hopes: Reports of Iran’s conditional offer to pause its nuclear program calmed global nerves

🕊️→ Rupee Recovery: INR bounced back 55 paise from record lows, supported by RBI intervention

🇮🇳→ Heavyweight Support: Reliance (RIL) & Metal stocks led the charge; crude oil volatility stabilized.

→ Institutional Action: FII selling exhausted; DIIs continued their massive buying streak to stabilize the ship.

Institutional Flow
→ FIIs remained net sellers but slowed the pace: -₹3752 Cr 📉
→ DIIs continued their massive support: +₹5152Cr

📈 Big Gainers: Adani Ports 🔥, Hindalco, L&T, Reliance, BEL📉

Laggards: Tech Mahindra, ICICI Bank, HCL Tech (IT under pressure)

🧭 Key Levels to Watch:

Support: 24,300 (Strong base formed)
Resistance: 24,900–25,000 (Morning Star pattern hints at more upside if 24,850 breaks)

👇 Is the bottom in, or is this just a dead cat bounce?Drop your view below! 🗳️#Nifty50 #StockMarketIndia #Sensex #Investing #DalalStreet #MarketRecovery #Nifty

[Stocks_Info_Adda @prasad0220]

Fractal Analytics Q3 Results: Post-IPO Growth Momentum! 🚀

India's first pure-play enterprise AI firm, Fractal has reported its Q3 FY26 numbers.
Top-line remains robust as the company pivots from a services-led model to an AI platform powerhouse.

📊 The Scorecard (Consolidated):
🔹 Revenue: ₹8,544 Mn (⬆️ 21% YoY) — Strong enterprise demand for AI.
🔹 PAT: ₹1,001 Mn (⬆️ 8.6% YoY / ⬆️ 201% QoQ) — Supercharged by a ₹499 Mn deferred tax credit.
🔹 Core Segment: https://t.co/cmCCE60t1L continues to dominate, contributing 98% of total revenue.
🔹 IPO Success: Raised ₹10,235 Mn in fresh capital to deleverage and fund global expansion.

✨ Key Developments & Strategic Wins:
✅ M&A Consolidation: Finalized 100% acquisition of Analytics Vidhya for ₹487 Mn to bolster its AI talent ecosystem.

✅ Innovation Moat: Launched PiEvolve, a world-class agentic AI engine that ranks among the top performers on OpenAI’s MLE-Bench globally.

✅ Blue-Chip Trust: Portfolio includes 122 "Must Win Clients" (Fortune 500s) including Google, Microsoft, and Citibank.

🧭 Future Prospects & Growth Levers:
🚀 Platform Pivot: Targeting 20% of revenue from high-margin proprietary platforms (like Cogentiq and https://t.co/CeEcbsj1k6) within 3-4 years.
🌍 Global Expansion: Using IPO proceeds to scale operations in the US and set up new AI-ready office infrastructure in India.
🏥 Healthcare AI: Massive upside potential from its subsidiary https://t.co/OGyCyJJ26u, a global leader in medical imaging AI.

The Bottom Line: While the stock saw a cautious debut, Fractal is transitioning into a scalable growth phase. With a strong cash pile and a leadership position in the "Agentic AI" era, the focus is now on margin expansion and platform monetization.

Is $FRACTAL the best way to play the Indian AI boom? 🇮🇳💻
Drop your view below! 👇

#FractalAnalytics #StockMarketIndia #AI #Nifty #Investing #Q3Results #AgenticAI #DataScience #FRACTAL #Sensex

[Stocks_Info_Adda @prasad0220]

2025: “Buy the dip.”
2026:
Buy the dip →
Dip dips →
Dip dips again →
Portfolio:
“Bro this is not a dip anymore… this is a swimming pool.” 🏊‍♂️📉
#Nifty50 #investing #StockMarketIndia #dalalstreet #meme

[Stocks_Info_Adda @prasad0220]

Middle East tensions trigger market panic — Nifty tumbles 385 pts as FIIs dump stocks! ⚠️

Nifty50 Recap | 4 March 2026

Nifty crashed ~385 pts ↓ to 24,480 (-1.55%)
Sensex tanked 1,122 pts to 79,116 (-1.40%)

💣 Why?
→ US-Israel-Iran war fears
→ Crude oil surge amid Middle East tensions 🛢️
→ FIIs dumped ₹8,753 Cr. DIIs absorbed the fall (₹12,068 Cr bought)

📉 Big Losers: L&T, IndiGo, HDFC Bank, Adani Ports
📈 Survivors: Bharti Airtel 🔥, BEL, ONGC
🧭 Key Levels to Watch:
Support → 24,200–24,300
Resistance → 25,000 (heavy call writing here)
👇 Is this a buying dip or more pain ahead?
Drop your view below! 🗳️
#Nifty50 #Nifty #StockMarket #IndianMarkets #Sensex #Investing #DalalStreet